window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : August 24, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Phase 1

  • Advanced Therapies,Clinical & Regulatory,Manufacturing & Supply Chain,Research & Development

    First UK patient dosed in personalised lung cancer vaccine trial using Touchlight DNA technology

    The first UK patient has been dosed with a personalised [...]

    July 30, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development

    Verdiva Bio starts Phase 1 trial of once-weekly oral amylin drug for obesity

    Verdiva Bio has dosed the first patient in a Phase [...]

    July 30, 2026
  • Advanced Therapies,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    Enterome data link CD8 T-cell expansion to progression-free survival in lymphoma

    Enterome Phase 1/2 data show EO2463-induced CD8 T-cell expansion was [...]

    July 22, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Research & Development

    Mission Therapeutics signs US$292M deal for acute kidney injury programme

    Mission Therapeutics has signed a deal worth up to US$292 [...]

    July 20, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Research & Development,Therapeutic Areas

    Kairos reports positive interim Phase 1 safety data for ENV-105 in EGFR-mutated lung cancer

    Kairos Pharma has reported positive interim safety results from an [...]

    July 16, 2026
  • Clinical & Regulatory,Drug Delivery & Formulation,Pharmaceuticals and therapeutics,Research & Development

    Rani reports positive Phase 1 data for oral obesity therapy RT-114

    Rani Therapeutics has reported positive initial Phase 1a data for [...]

    July 16, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development

    AMR Action Fund leads €18M Series A for Telum Therapeutics

    Telum Therapeutics has raised €18 million in a Series A [...]

    July 2, 2026
  • Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    Innovative Molecules adds Epstein-Barr virus antiviral programme to pipeline

    Innovative Molecules has expanded its virology pipeline with a new [...]

    June 16, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    Confo Therapeutics reports preclinical data for post-bariatric hypoglycaemia candidate at ENDO 2026

    Confo Therapeutics has presented preclinical data supporting the development of [...]

    June 16, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    PhoreMost advances brain cancer candidate PMC-001 towards Phase 1

    PhoreMost has unveiled its lead oncology programme, PMC-001, as the [...]

    June 11, 2026
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • MaxCyte launches off-target assays for adenine and cytosine base editors
    Categories: Advanced Therapies, Clinical & Regulatory, Digital & Data, Genomics and sequencing
  • VectorBuilder and Lir Therapeutics partner on AI-guided AAV capsid engineering
    Categories: Advanced Therapies, Digital & Data, Drug Discovery & Development, Manufacturing & Supply Chain
  • Wiley launches spectral analysis APIs for faster compound identification
    Categories: Digital & Data, Drug Discovery & Development, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top